SBSN: A Large Molecule with Potential as A Drug Target and Biomarker

Target Name: SBSN

NCBI ID: G374897

SBSN

SBSN: A Large Molecule with Potential as A Drug Target and Biomarker

SBSN ( Small-in-large nucleotide) is a molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. SBSN is a key component of the cell membrane, which acts as a barrier between the cell and the surrounding environment. It is made up of several different nucleotides, which are the building blocks of DNA and RNA.

One of the key features of SBSN is its large size, as the name suggests. It is about the size of a small car, and it has a diameter of around 50 nanometers. This makes it a very large molecule, which can interact strongly with other molecules in the body.

SBSN has been shown to be involved in many different processes in the body, including the regulation of cell growth, differentiation, and death. It has also been linked to a number of diseases, including cancer. For example, studies have shown that SBSN levels are often elevated in cancer cells, and that inhibiting SBSN activity may be a promising strategy for cancer treatment.

In addition to its potential as a drug target, SBSN has also been shown to be a potential biomarker for a number of diseases. For example, SBSN levels have been shown to be elevated in the blood of people with heart disease, and that these levels may be a useful diagnostic marker for heart disease. Similarly, SBSN levels have been shown to be elevated in the urine of people with diabetes, and that these levels may be a useful diagnostic marker for diabetes.

SBSN has also been shown to play a key role in the regulation of cell signaling pathways. For example, SBSN has been shown to interact with the protein PDGF-BB, which is involved in cell signaling and growth. This interaction suggests that SBSN may be a useful target for drugs that are designed to inhibit cell signaling pathways.

In conclusion, SBSN is a molecule that has significant potential as a drug target and biomarker. Its large size and the many different processes it is involved in make it an attractive target for drug development. Further research is needed to fully understand the role of SBSN in the body and its potential as a drug and biomarker.

Protein Name: Suprabasin

The "SBSN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SBSN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets